Securing the Future: Why Track and Trace is Essential for Compliance and Growth

The global market for track and trace solutions was valued at USD 3.5 billion in 2022 and is projected to grow at an impressive compound annual growth rate (CAGR) of 19.3% from 2023 to 2030. This growth can be largely attributed to the increasing rates of counterfeiting and theft of healthcare products on a global scale. Manufacturers in biopharmaceutical, pharmaceutical, cosmetic, and medical device sectors are progressively adopting track and trace solutions to secure their products and protect brand integrity. In addition, favorable regulations that encourage serialization implementation further support the adoption of track and trace technology across the healthcare industry, ensuring a secure supply chain for products susceptible to fraud and misappropriation.

The demand for track and trace solutions is expected to increase significantly as more pharmaceutical and medical device companies deploy these systems. Counterfeiting in the pharmaceutical industry is a critical issue, prompting companies to implement track and trace solutions to monitor their supply chains and ensure product authenticity. The problem of counterfeit and substandard medications is especially pervasive in low- to middle-income countries, such as India and African nations. According to a 2019 report from the United States Trade Representative (USTR), approximately 20% of all drugs sold in India are counterfeit, illustrating the urgent need for secure tracking systems in these regions.

Counterfeiting and theft are major challenges for companies in the pharmaceutical, biopharmaceutical, and cosmetic industries. The World Health Organization (WHO) estimates that around 10% of all medicines globally are counterfeit, with some African, Asian, and Latin American countries experiencing counterfeiting rates as high as 10% to 30%. The consequences of consuming fake medicines are grave, with thousands of deaths occurring annually. In response, governments worldwide are establishing stringent standards and regulations to mandate the use of track and trace solutions within the healthcare industry. Advances in technology, such as Radio Frequency Identification (RFID), have further driven the adoption of track and trace in the supply chain, enhancing security and transparency. By 2018, it was estimated that over 40 countries and more than 75% of the global medicine supply would be under track and trace regulations. However, the high cost of implementing these systems remains a potential obstacle to market growth.

Gather more insights about the market drivers, restrains and growth of the Track And Trace Solutions Market

Regional Insights:

North America:

In terms of regional market insights, North America held the largest share of revenue, accounting for over 35.0% in 2022. This dominance is primarily due to the presence of strict serialization and aggregation standards as well as a highly advanced healthcare infrastructure. The U.S. Food and Drug Administration (FDA) recommends that pharmaceutical and healthcare companies adopt automatic identification technologies, such as barcoding and RFID, to enhance supply chain transparency. With highly developed healthcare infrastructure and robust technology adoption, particularly in the U.S., North America is expected to maintain its leading position in the market.

Europe:

Europe emerged as the second-largest market for track and trace solutions by revenue and is anticipated to retain this position through 2030. This region’s growth can be attributed to the presence of advanced economies, including Germany, Turkey, the U.K., France, and Italy. The European Union is implementing track and trace solutions across the healthcare supply chain as a measure against drug counterfeiting and theft. Under the Falsified Medicines Directive, manufacturers who fail to comply with serialization regulations are prohibited from marketing their products within Europe, highlighting the region's strong regulatory framework in combatting counterfeit medicines.

Browse through Grand View Research's Healthcare IT Industry Research Reports.

The Middle East and Africa telehealth market sizewas estimated at USD 4.51 billion in 2024 and is projected to grow at a CAGR of 26.8% from 2025 to 2030.

The global teledentistry market sizewas estimated at USD 2.02 billion in 2024 and is projected to grow at a CAGR of 15.3% from 2025 to 2030.

Key Companies & Market Share Insights

The global market for track and trace solutions is highly competitive, with numerous small and large manufacturers offering a wide array of products tailored to tracking and tracing applications. This market dynamic has led to fierce competition among vendors who are continually seeking ways to enhance their offerings and expand their market reach. One common strategy is to forge strategic partnerships with customers and collaborate with other industry players to pool expertise and resources.

For instance, in January 2022, Optel Group made a strategic acquisition by purchasing the track and trace unit of Korber Business Area Pharma, also known as Taxeed. Taxeed, based in Germany, has a strong background in agrochemical and pharmaceutical tracking technologies, and this acquisition has allowed Optel to benefit from Taxeed’s specialized knowledge in these fields. Similarly, Rfxcel, a subsidiary of Antares Vision Group, entered into a significant partnership in September 2021. They signed a five-year cooperative agreement with the Ministry of Public Health in the Lebanese Republic to establish a GS1-compliant traceability hub. This hub is aimed at securing the entirety of Lebanon’s pharmaceutical supply chain, enhancing transparency, and reducing the risk of counterfeit drugs. Such collaborations underscore the increasing importance of strategic partnerships in driving market growth and meeting regulatory compliance across the track and trace sector.

Key Track And Trace Solutions Companies

Some prominent players in the global track and trace solutions market include: